# FDA 483 - Richard Dumas - March 29, 2018

Source: https://www.globalkeysolutions.net/records/483/richard-dumas/f6b181e6-2ccf-487a-bee2-3dcee39d125c

> FDA 483 for Richard Dumas on March 29, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Richard Dumas
- Inspection Date: 2018-03-29
- Product Type: drugs
- Office Name: Center for Veterinary Medicine
- Summary: Richard Dumas, a clinical investigator in Laval, was inspected by the FDA and cited for significant deficiencies in clinical trial conduct. The inspection revealed failures in obtaining legally effective informed consent, not conducting investigations according to the protocol, and inadequate maintenance of case histories. These issues primarily affected the CANVAS and CANVAS-R clinical studies.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/camille-d-brown/419869d2-1810-40ea-8e8a-687de7013f6a)

Company: https://www.globalkeysolutions.net/companies/richard-dumas/8d0f0274-c2d4-4781-85a6-2102a8469695

Office: https://www.globalkeysolutions.net/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4